DelveInsight’s “Alopecia Areata Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Alopecia Areata market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Alopecia Areata market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Alopecia Areata: An Overview
According to the National Alopecia Areata Foundation, Alopecia Areata (AA) is a common autoimmune skin disease, which causes hair loss on the scalp, face, and at times on other areas of the body. The affected hair follicles are attacked by a person’s immune system (white blood cells), which results in the seizing of the hair growth stage. Hair follicles remain alive, and hair can regrow at any time in Alopecia Areata.
Alopecia Areata usually begins with one or more patches which may be small, round, or smooth on the scalp that can progress to total scalp hair loss or complete body hair loss. Genetic predisposition and environmental factors increase the chances of developing Alopecia Areata.
Alopecia Areata Market Key Facts
According to Chantal Bolduc et al., 2018, the prevalence of alopecia areata (AA) in the general population is estimated to be 0.1–0.2%. The lifetime risk of developing alopecia areata is estimated to be 1.7%. All races are affected equally by alopecia areata, and no increase in prevalence has been found in a particular ethnic group.
As per the NORD, alopecia areata is most common among children, and approximately 2.5 million people are suffering from alopecia areata in the United States.
As per Herbert Pratt et al. 2017, alopecia areata affects approximately two percent of the general population at some point during their lifetime
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Alopecia Areata market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Alopecia Areata market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.
Alopecia Areata Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders.
Alopecia Areata Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Alopecia Areata market or expected to get launched during the study period. The analysis covers the Alopecia Areata market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Alopecia Areata Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How Alopecia Areata Market Will Evolve by 2032 @
Alopecia Areata Therapeutics Analysis
Currently, there is no cure and no FDA-approved treatments for alopecia. The alopecia areata (AA) is the most common form of alopecia and is characterized by patchy scalp baldness. The potential for hair recovery is maintained, but, at present, there is no treatment able to induce a permanent remission of this disease or approved to treat it. Thus, the market is completely dominated by off-label drug therapies.
Some of the key players involved in developing therapies for Alopecia Areata include:
Suzhou Zelgen Biopharmaceuticals
Eli Lilly and Company
Alcaris Therapeutics Inc.
And many others.
Alopecia Areata Therapies covered in the report include:
And many others.
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More @
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Alopecia Areata Competitive Intelligence Analysis
4. Alopecia Areata Market Overview at a Glance
5. Alopecia Areata Disease Background and Overview
6. Alopecia Areata Patient Journey
7. Alopecia Areata Epidemiology and Patient Population (In the US, EU5, and Japan)
8. Alopecia Areata Treatment Algorithm, Current Treatment, and Medical Practices
9. Alopecia Areata Unmet Needs
10. Key Endpoints of Alopecia Areata Treatment
11. Alopecia Areata Marketed Products
12. Alopecia Areata Emerging Drugs and Latest Therapeutic Advances
13. Alopecia Areata Seven Major Market Analysis
14. Attribute Analysis
15. Alopecia Areata Market Outlook (In US, EU5, and Japan)
16. Alopecia Areata Access and Reimbursement Overview
17. KOL Views on the Alopecia Areata Market
18. Alopecia Areata Market Drivers
19. Alopecia Areata Market Barriers
21. DelveInsight Capabilities
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report @
Other Trending Healthcare Reports By DelveInsight
DelveInsight’s “Alopecia Areata Pipeline Insight” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Alopecia Areata pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States